DXB 6.48% 57.5¢ dimerix limited

Ann: Dimerix Presents at ASX Small & Mid-Cap Conference, page-71

  1. 433 Posts.
    lightbulb Created with Sketch. 211
    another smart ar$e I see.
    ///your 1st paper shows you need to reduce proteinuria by at least 50% or to below 1g /day in the 1st year to be protective long term
    ///your 2nd paper says reducing proteinuria by at least 40% and to below 1.5 g/ day gives better long term outcome in fsg
    ///your 3rd paper does have some charts at the end with GFR slope change by every 10% drop in proteinuria, but they don't correlate this with any quantifiable survival outcome or time to end stage kidney disease.
    ....so I ask again, the SPECIFIC claim "10% proteinuria decline gives 5-6 extra years life" ,on what is that based, where is that stated?
    if anything your 1st 2 papers highlight the relative weakness of the dimx drug because it hasn't demonstrated anything like those sorts of proteinuria reductions, has it?
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
57.5¢
Change
0.035(6.48%)
Mkt cap ! $316.0M
Open High Low Value Volume
54.0¢ 58.0¢ 53.0¢ $2.646M 4.754M

Buyers (Bids)

No. Vol. Price($)
1 20000 57.0¢
 

Sellers (Offers)

Price($) Vol. No.
57.5¢ 9999 1
View Market Depth
Last trade - 16.10pm 07/06/2024 (20 minute delay) ?
Last
57.5¢
  Change
0.035 ( 7.26 %)
Open High Low Volume
53.0¢ 58.0¢ 52.5¢ 2466717
Last updated 15.59pm 07/06/2024 ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.